Unique ID issued by UMIN | UMIN000041225 |
---|---|
Receipt number | R000047077 |
Scientific Title | Exploratory study of food material on abdominal visceral fat-Randomized, double-blind, placebo-controlled parallel group study- |
Date of disclosure of the study information | 2020/07/28 |
Last modified on | 2021/02/15 17:52:08 |
Exploratory study of food material on abdominal visceral fat-Randomized, double-blind, placebo-controlled parallel group study-
Exploratory study of food material on abdominal visceral fat
Exploratory study of food material on abdominal visceral fat-Randomized, double-blind, placebo-controlled parallel group study-
Exploratory study of food material on abdominal visceral fat
Japan |
Not applicable
Adult |
Others
NO
To investigate the effect of intake of food material for 12 weeks on abdominal fat area reduction and safety in males with abdominal obesity aged 20-64
Safety,Efficacy
Visceral fat area
Subcutaneous fat area, total fat area, Body weight, BMI, Body fat percentage, Waist circumference, blood pressures (systolic and diastolic),AST(GOT),ALT(GPT),gamma-GT, total cholesterol, HDL- cholesterol, LDL- cholesterol triglyceride, glucose,sample size estimation
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
Intake of study food for 12 weeks
Intake of placebo food for 12 weeks
20 | years-old | <= |
65 | years-old | > |
Male
1)Males equal to or more than 20 years and less than 65 years
2)Subjects with BMI >=25 kg/m2 and <30 kg/m2
3)Subjects who visit on schedule days
4)Subjects who recognize the object and contents of the study and submit the written informed consent
1)Subjects who have a history of severe illness and current medical history in the heart, liver, kidney, digestive organs
2)Subjects who dyslipidemia, high blood pressure, diabetes
3)Subjects who use drugs affecting lipid metabolism, blood pressure or carbohydrate metabolism
4)Subjects who received medication treatment or surgery due to serious illness or injury within 1 month from the start of this study
5)Subjects who regularly use drugs, health foods, and supplements affecting the study
6)Heavy dinker
7)Subjects who feel bad mood by blood collection in past
8)Subjects who donated 200 mL or more of blood within 1 month from the start of the study or subjects who plan to do so during the study period
9)Subjects who have been constipated for more than 5 days
10)Shift worker
11)Subjects who plan business trip or trip for 10 days or more a month
12)Subjects who have allergy related to the study foods
13)Subjects already participating in other clinical trials
14)Subjects who are ineligible due to physician's judgment
30
1st name | Ikuo |
Middle name | |
Last name | Fukuhara |
Fukuhara Clinic
Hospital director
061-1351
3-1-15 Shimamatsuhigashi-machi, Eniwa, Hokkaido, Japan
0123-36-8029
i-feniwa@gray.plala.or.jp
1st name | Tomoya |
Middle name | |
Last name | Yuhki |
New drug research center, Inc.
Clinical Research Dept.
061-1405
452-1 Toiso, Eniwa-shi, Hokkaido, Japan
0123-34-0412
t-yuhki@ndrcenter.co.jp
Maruzen Pharmaceuticals Co., Ltd.
Maruzen Pharmaceuticals Co., Ltd.
Profit organization
Fukuhara Clinic Clinical Trial Review Committee
1-15, Shimamatsuhigashimachi-3-chome, Eniwa-shi, Hokkaido
0123-36-8029
d-kameda@mediffom.co.jp
NO
2020 | Year | 07 | Month | 28 | Day |
Unpublished
Completed
2020 | Year | 07 | Month | 15 | Day |
2020 | Year | 07 | Month | 14 | Day |
2020 | Year | 08 | Month | 27 | Day |
2020 | Year | 11 | Month | 28 | Day |
2020 | Year | 07 | Month | 27 | Day |
2021 | Year | 02 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047077